According to BlockBeats, Huajian Medical, a Hong Kong-listed company (01931.HK), has announced plans to seek shareholder approval for a cryptocurrency purchase authorization. The board considers the acquisition and holding of cryptocurrencies as a crucial step in strengthening the group's Ethereum (ETH) reserves and advancing the development of the ivd.xyz trading platform ecosystem. This initiative is also seen as a vital component of the group's asset allocation strategy.
After careful consideration, the board has proposed to obtain prior approval from shareholders to grant purchase authorization. This would allow the board to formally pass a resolution at a special shareholder meeting, enabling potential cryptocurrency purchases within a 36-month period from the date of the resolution. The total purchase amount is not to exceed 3 billion Hong Kong dollars.
